Akomapa Health
Improving healthcare access and outcomes in underserved communities through student-powered clinics.
Website: https://www.akomapa.org/
Cover Block
PUBLIC
| Field | Value |
|---|---|
| Name | Akomapa Health |
| Tagline | Improving healthcare access and outcomes in underserved communities through student-powered clinics |
| Headquarters | Ghana and United States |
| Stage | Pre-Seed |
| Business Model | Social Enterprise / Nonprofit Hybrid |
| Industry | Healthtech (chronic disease primary care) |
| Geography | Sub-Saharan Africa, with U.S. linkages |
| Growth Profile | Social Enterprise / Nonprofit Hybrid |
| Accelerator | Startup Yale [Startup Yale] |
Links
PUBLIC
- Website: https://www.akomapa.org/
- LinkedIn: https://www.linkedin.com/company/akomapa-student-run-free-clinics
- Founder LinkedIn (Brian Fleischer): https://www.linkedin.com/in/brian-fleischer-37011010b/
- Yale School of Medicine profile (Brian Fleischer): https://medicine.yale.edu/profile/brian-fleischer/
- Startup Yale profile: https://startup.yale.edu/person/akomapa-health-foundation/
Executive Summary
PUBLIC
Akomapa Health is an early-stage healthcare initiative building student-run free clinics that deliver screening, treatment, and longitudinal follow-up for hypertension and diabetes in underserved communities across Ghana and the United States [Startup Yale]. The organization sits at the intersection of academic medicine and community health, structured as a social enterprise / nonprofit hybrid rather than a venture-backed company, and was incubated through the Startup Yale program at Yale University [Startup Yale]. Its founding figure of public record is Brian Fleischer, an internal medicine resident physician at Yale New Haven Hospital, who lists Akomapa on his professional profile as the clinic network he is building [LinkedIn]. The model is built around university-community partnerships in which student volunteers operate clinics under expert supervision, with an attached nutrition initiative branded Akomapa Foods that frames diet support as preventative primary care [Akomapa Health]. No funding rounds, revenue figures, or institutional investors are publicly disclosed at the time of writing, which is consistent with an organization in the philanthropic and grant-funded phase of formation. The strategic question for observers over the next 12 to 18 months is whether Akomapa can translate its Ghana flagship clinic at the University of Ghana into a replicable network across additional African universities and U.S. academic medical centers, and whether it can attract the catalytic philanthropic capital that NCD-focused programs in low- and middle-income countries typically require [PMC]. For impact-oriented funders, the appeal is a low-cost delivery model focused on the two largest non-communicable disease burdens in Sub-Saharan Africa; the open question is governance maturity and the path from pilot clinic to enduring institution.
Data Accuracy: YELLOW -- Confirmed by Startup Yale and the organization's own website; founding year and full team roster not publicly disclosed.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed (philanthropic / pre-institutional) |
| Business Model | Social Enterprise / Nonprofit Hybrid |
| Industry / Vertical | Healthtech, primary care for chronic NCDs |
| Technology Type | No core technology component disclosed |
| Geography | Ghana and United States |
| Growth Profile | Mission-driven, replication-based |
Company Overview
PUBLIC
Akomapa Health presents itself as a network of student-powered, community-rooted clinics designed to scale chronic disease care in settings where primary care is thin on the ground [Akomapa Health]. The organization's public materials describe a deliberately simple operating premise: pair a university with a community, equip supervised students to run a recurring clinic, focus on a small number of high-burden conditions, and build longitudinal follow-up rather than one-off screening events [Akomapa Health]. The flagship site referenced on the organization's clinics page is the Akomapa UG Clinic associated with the University of Ghana [Akomapa Health].
The founding story available in public sources runs through Yale. Akomapa Health Foundation is profiled on the Startup Yale roster, the university's startup support program, and is described there as "a scalable model for chronic disease care in Ghana and the United States" [Startup Yale]. Brian Fleischer, an internal medicine resident at Yale New Haven Hospital, identifies on his LinkedIn profile as building Akomapa Student Run Free Clinics [LinkedIn], and his Yale School of Medicine profile confirms his clinical affiliation [Yale School of Medicine]. The full founding team is not enumerated in public sources, although LinkedIn lists additional volunteer leadership in Ghana, including a marketing and communications chairperson at the Akomapa LEO Club [LinkedIn].
Key milestones available in public sources are limited. The organization has stood up the Akomapa UG clinic in Ghana, launched an Akomapa Foods nutrition program described as part of preventative primary care, and operates an Akomapa Network and a Global Health Leadership Training Program (GHLTP) for student leaders [Akomapa Health]. A founding year is not stated on any of the company's own pages, and no incorporation details are publicly cited.
Data Accuracy: YELLOW -- Confirmed via Startup Yale, Yale School of Medicine, and the organization's website; legal entity details and founding date not publicly available.
Product and Technology
MIXED
The "product" Akomapa offers is a clinical service line rather than a software platform. According to the Startup Yale profile, the model centers on university-community partnerships in which student-run clinics deliver screening, treatment initiation, longitudinal follow-up, and education for hypertension and diabetes under expert supervision [Startup Yale] [PUBLIC]. The organization's website extends that picture, framing Akomapa as "building a model of student-powered, community-rooted healthcare that scales sustainably" [Akomapa Health] [PUBLIC]. The combination of a narrow clinical focus (two of the most common NCDs in Sub-Saharan Africa) with a low-cost staffing model (supervised students) is the central design choice.
Two connected programs are visible on the public site. Akomapa Foods is described as a nutrition support initiative woven into preventative primary care, reflecting the recognition that hypertension and type 2 diabetes management depends heavily on diet and lifestyle factors [Akomapa Health] [PUBLIC]. The Akomapa Global Health Leadership Training Program (GHLTP) is positioned as the talent pipeline that produces the supervised clinicians-in-training who staff the clinics, framing leadership development as a co-product alongside patient care [Akomapa Health] [PUBLIC]. The Akomapa Network page describes the broader connective tissue across sites [Akomapa Health] [PUBLIC].
The operational backbone is therefore people and protocols rather than software, which has implications both for capital intensity (lower) and for defensibility (depends on brand, partnerships, and clinical outcomes rather than on code) [Akomapa Health] [PUBLIC].
Data Accuracy: YELLOW -- Product description corroborated by Startup Yale and the organization's own website; no third-party clinical outcome studies are publicly cited.
Market Research and Opportunity
PUBLIC
The market context for Akomapa is one of the most-discussed gaps in global health: the rising burden of non-communicable diseases in Sub-Saharan Africa colliding with primary care systems that were largely designed for infectious disease.
A 2024 roundtable proceedings paper published in PMC on hypertension management in Ghana frames the problem directly, describing structural roadblocks to chronic disease control and calling for new models of community-based care, task-shifting, and longitudinal follow-up [PMC, 2024]. Hypertension and diabetes together represent the two largest chronic disease categories Akomapa targets, and the academic literature cited on PMC supports the demand-side case that current delivery infrastructure is not meeting need [PMC, 2024]. The published TAM/SAM/SOM figures specific to student-run NCD clinics in Ghana are not available from a named third-party report, so any precise sizing here would be speculative.
Demand drivers surfaced by the cited literature include epidemiological transition (rising prevalence of hypertension and type 2 diabetes as life expectancy and urbanization increase), workforce shortages in primary care, and the absence of a continuity-of-care layer between episodic hospital visits [PMC, 2024]. Adjacent and substitute markets include public-sector primary health centers, faith-based hospital networks (a historically important provider of rural care in Ghana), NGO-run vertical programs typically focused on HIV/TB/malaria, and pharmacy-led screening. Akomapa's positioning is distinct from each of these in that it pairs a teaching-hospital quality bar with a recurring, free, community-sited clinic.
Regulatory and macro forces worth tracking include Ghana's National Health Insurance Scheme coverage policies for chronic disease medications, donor priorities at major global health funders that have begun shifting marginal dollars from communicable to non-communicable disease, and U.S. academic medical center interest in global health partnerships as part of residency training. None of these are guaranteed tailwinds, but each is a directional positive for a model like Akomapa's [PMC, 2024].
| Cited claim | Source |
|---|---|
| Hypertension management in Ghana faces structural roadblocks requiring new community-based delivery models | [PMC, 2024] |
| Akomapa's model targets screening, treatment initiation, longitudinal follow-up, and education for hypertension and diabetes | [Startup Yale] |
| Akomapa Foods integrates nutrition support into preventative primary care | [Akomapa Health] |
The academic case for the category Akomapa operates in is well-documented in peer-reviewed sources, but Akomapa-specific market sizing has not been published, so investors should treat opportunity sizing as directional rather than quantified.
Data Accuracy: YELLOW -- Market context corroborated by PMC peer-reviewed proceedings; Akomapa-specific sizing not publicly disclosed.
Competitive Landscape
MIXED
Akomapa operates in a space where the competition is less a set of venture-funded startups and more a patchwork of public, faith-based, and NGO providers, plus a handful of academic global health programs [PUBLIC].
The competitive analysis below is drawn from the cited public sources and from the categories of providers that operate in the same patient population [PUBLIC].
At the segment level, the relevant alternatives fall into three groups. The first is the Ghanaian public primary care system, which delivers care through community-based health planning and services (CHPS) compounds and district hospitals; this is the default option for most patients and is broadly accessible but, as the PMC proceedings document, struggles with continuity for chronic conditions [PMC, 2024]. The second is the network of mission and faith-based hospitals that historically anchor rural care; these are well-established and trusted but rarely run dedicated NCD clinics aimed at upstream screening. The third is the global health programmatic layer (large international NGOs and academic-medical-center partnerships) that has historically over-indexed on infectious disease and is only recently turning toward NCDs [PMC, 2024] [PUBLIC].
Where Akomapa has a defensible edge today, the evidence points to three things. First, a credible academic anchor in Yale, surfaced through the Startup Yale program and the founder's clinical role at Yale New Haven Hospital, which gives the organization access to clinical supervision, student talent, and philanthropic networks that pure community NGOs lack [Startup Yale] [Yale School of Medicine] [PUBLIC]. Second, a tightly scoped clinical focus (hypertension and diabetes) that is easier to standardize than a full primary care offering [Startup Yale] [PUBLIC]. Third, a workforce model built on supervised students, which dramatically reduces variable cost per visit relative to physician-staffed clinics [Akomapa Health] [PUBLIC]. The durability question for each: the Yale anchor is strong while founder-affiliated leadership is in residency, and will need to institutionalize beyond a single cohort; the clinical focus is durable as long as the disease burden persists; the student workforce model depends on continued university partnerships [PRIVATE].
Where Akomapa is most exposed is in three named directions. The Ghanaian public system can, in principle, scale CHPS-based NCD protocols faster than any nonprofit if national policy and donor funding align, which would compress Akomapa's addressable gap [PMC, 2024]. Faith-based hospital networks have decades of community trust and physical infrastructure that a young organization cannot replicate quickly. And large international NGOs with multi-million-dollar budgets could choose to fund parallel student clinic models through existing university partners. The 18-month scenario worth watching: Akomapa wins if it publishes credible patient outcome data from the UG clinic and converts that evidence into a multi-site philanthropic round; it loses ground if a larger NGO launches a directly competing student-clinic program with deeper pockets before Akomapa institutionalizes [PRIVATE].
Data Accuracy: ORANGE -- Competitive set inferred from category knowledge and PMC literature; no head-to-head competitor data is publicly disclosed for Akomapa specifically.
Opportunity
PUBLIC
If Akomapa executes, the prize is becoming the default student-clinic infrastructure for chronic disease care across African teaching universities, with a parallel U.S. footprint that links residency training to global health.
The headline opportunity. The single largest plausible outcome is that Akomapa becomes the standard operating model that academic medical centers in Sub-Saharan Africa adopt for community-based hypertension and diabetes care, in the way that a handful of named global health programs have become the default operating models in their own categories. The conditions that make this reachable rather than aspirational are documented: peer-reviewed sources describe an unmet need for community-based, longitudinal NCD care in Ghana specifically [PMC, 2024]; the organization has a working flagship clinic at the University of Ghana [Akomapa Health]; and it has an academic anchor and accelerator credential through Startup Yale that unlocks both clinical credibility and philanthropic introductions [Startup Yale]. The opportunity is real because the gap is real; the question is execution speed and capital.
Growth scenarios.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| University network replication | Akomapa stands up clinics at 5-10 additional African teaching universities over 3-5 years | A multi-year grant from a major global health funder underwrites the replication kit | Peer-reviewed literature documents demand for community NCD models [PMC, 2024]; Akomapa already has a replicable UG flagship [Akomapa Health] |
| U.S. residency partnership flywheel | Akomapa becomes the structured global health rotation for multiple U.S. internal medicine residency programs | Yale residency program formalizes the rotation, signaling other academic centers | Founder is a Yale internal medicine resident actively building the clinics [LinkedIn]; Startup Yale provides institutional cover [Startup Yale] |
| Integrated nutrition + clinic platform | Akomapa Foods becomes a recognized adjunct to NCD care, attracting food-systems philanthropy alongside health funding | A named food-systems funder co-invests with a global health funder | Akomapa already operates Akomapa Foods as a nutrition arm of preventative care [Akomapa Health] |
What compounding looks like. The flywheel for an organization like Akomapa is not a software network effect; it is a credibility-and-talent flywheel. Each successful clinic produces (a) clinical outcome data that supports the next grant application, (b) trained student leaders who can stand up the next site, and (c) a deeper reference network of academic and community partners. The Akomapa Global Health Leadership Training Program is explicitly designed to produce the human capital layer of that flywheel, framing leadership development as a co-output of the clinical work [Akomapa Health]. Evidence that the flywheel is starting is visible in the organization's network and partner pages, though the underlying outcome data has not been published in the cited sources.
The size of the win. A direct public market comparable does not exist because Akomapa is structured as a nonprofit hybrid rather than as an equity-backed company. A more useful frame is philanthropic scale: well-known global health delivery organizations focused on a single disease area or geography have grown to nine-figure annual budgets over 10-20 years when they combine credible clinical evidence with strong academic anchors. If the university network replication scenario plays out and Akomapa reaches 10 sites with documented outcomes, an annual operating budget in the low eight figures is a directionally reasonable scenario, not a forecast. The realistic upside for impact-aligned funders is therefore a category-defining nonprofit institution rather than a venture exit, and the diligence question is whether the team and governance can carry it there.
Data Accuracy: YELLOW -- Scenarios grounded in cited sources for product, accelerator, and market context; outcome data and budget figures not publicly disclosed.
Sources
PUBLIC
[Startup Yale] Akomapa Health Foundation profile | https://startup.yale.edu/person/akomapa-health-foundation/
[Akomapa Health] Akomapa Health home | https://www.akomapa.org/
[Akomapa Health] About Us | https://www.akomapa.org/about
[Akomapa Health] Clinics | https://www.akomapa.org/clinics
[Akomapa Health] Akomapa UG Clinic | https://www.akomapa.org/clinics/akomapa-ug
[Akomapa Health] Akomapa Foods | https://www.akomapa.org/programs/akomapa-foods
[Akomapa Health] The Akomapa Network | https://www.akomapa.org/programs/akomapa-network
[Akomapa Health] Global Health Leadership Training Program | https://www.akomapa.org/programs/akomapa-ghltp
[Akomapa Health] Partner | https://www.akomapa.org/partner
[Akomapa Health] Donate | https://www.akomapa.org/donate
[LinkedIn] Akomapa Student-Run Free Clinic company page | https://www.linkedin.com/company/akomapa-student-run-free-clinics
[LinkedIn] Brian Fleischer profile | https://www.linkedin.com/in/brian-fleischer-37011010b/
[LinkedIn] Clara Oforiwaa Agbenyegah profile | https://www.linkedin.com/in/clara-oforiwaa-agbenyegah-91a917253/
[Yale School of Medicine] Brian Fleischer faculty profile | https://medicine.yale.edu/profile/brian-fleischer/
[PMC, 2024] Addressing the roadblocks to hypertension management in Ghana: proceedings of a roundtable discussion | https://pmc.ncbi.nlm.nih.gov/articles/PMC11465716/
Articles about Akomapa Health
- Akomapa Health Is Putting Student-Run Clinics Between Ghanaians and a Hypertension Crisis — The Yale-incubated nonprofit hybrid is screening for diabetes and high blood pressure in communities where chronic care often stops at diagnosis.